港股市场个股详情

06660 艾美疫苗

添加自选

8.380
+0.130+1.58%

已收盘 04/29 16:08 (北京)

101.49亿总市值-7071市盈率TTM

艾美疫苗股票讨论区

登录发表评论

Moomoo AI

2023/12/02 08:42

The high level of insider ownership and willingness to buy shares at prices exceeding current market indicate a bullish outlook for AIM Vaccine. The recent loss did not dampen their enthusiasm, identifying it as a potential watchlist candidate for investors.

AIM Vaccine Insider Ups Holding By 649% During Year

Moomoo AI

2023/10/24 08:56

艾美疫苗的回购显示出管理层对未来发展的信心。医药行业将迎来新景气度上升周期，作为全链疫苗集团，艾美疫苗的价值显现。重磅产品如13价结合肺炎疫苗将助其业绩开辟更大想象空间。艾美疫苗深厚研发底蕴与产品升级，加管理层回购及新品种进展，预示其股价有大幅上升空间。

从股票回购到研发布局，解读艾美疫苗(06660)被低估的成长潜力

Steven000

2023/03/27 13:01

$艾美疫苗(06660.HK)$
圆弧底形态，5日均线上穿10日均线，MACD水上金叉，短线依旧看涨，注意后期MACD出现顶背离的风险，控制仓位，快进快出。

Spinee

2022/12/14 14:12

The domestic COVID-19 oral drug Azifodine is planned to be sold online, and $复星医药(02196.HK)$ shares were opened 12% higher to 29 yuan.
$辉瑞(PFE.US)$$艾美疫苗(06660.HK)$